FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 72603-301 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerNorthStar Rx LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA207325
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20190617
Marketing ended20270331
Package count1

External sources

Source: openFDA. Public-domain (CC0).